# Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants

> **NCT04323124** · PHASE1 · TERMINATED · sponsor: **Pfizer** · enrollment: 61 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-07059013
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04323124
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-17
- **Primary completion:** 2021-10-21
- **Final completion:** 2021-10-21
- **Target enrollment:** 61 (ACTUAL)
- **Why stopped:** Study was terminated as it did not demonstrate sufficient pharmacological effect. Termination was not related to safety reasons.
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04323124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04323124, "Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04323124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*